A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Hereditary haemochromatosis (HH), which affects some 1 in 400 and has an estimated carrier frequency of 1 in 10 individuals of Northern European descent, results in multi-organ dysfunction caused by increased iron deposition, and is treatable if detected early. Using linkage-disequilibrium and full haplotype analysis, we have identified a 250-kilobase region more than 3 megabases telomeric of the major histocompatibility complex (MHC) that is identical-by-descent in 85% of patient chromosomes. Within this region, we have identified a gene related to the MHC class I family, termed HLA-H, containing two missense alterations. One of these is predicted to inactivate this class of proteins and was found homozygous in 83% of 178 patients. A role of this gene in haemochromatosis is supported by the frequency and nature of the major mutation and prior studies implicating MHC class I-like proteins in iron metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HFE encodes an atypical MHC class I molecule which plays a major role in the regulation of iron homeostasis under basal conditions (Feder et al., 1996; Ludwiczek et al., 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Feder et al., 1996
In the citing paper
“Two decades later that insight led to the identification of HFE (originally called HLA-H), the gene mutated in the large majority of patients with hemochromatosis.121”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [121]
In the citing paper
“This mutation disrupts the formation of the disulfide bridge, which appears to be necessary for proper protein formation, causing the aberrant protein remains in the Golgi (24, 83).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
In the citing paper
“Normal HFE protein associates with TfR, usually in conjunction with β2-microglobulin, and competes with Tf for TfR binding, thereby inhibiting Fe-Tf uptake via the TfR in cells (83, 179).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928
Shizuya, H., Birren, B., Kim, U. J., Mancino, V, Slepak, T., Tachiiri, Y., & Simon, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8794 · Cited by 1,671
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Current Protocols in Human Genetics
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142905 · Cited by 987
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 881
A new bacteriophage P1–derived vector for the propagation of large human DNA fragments
loannou, P. A., Amemiya, C. T., Garnes, J., Kroisel, P. M., Shizuya, H., Chen, C., Batzer, M. A., & de Jong, P. J. (1994) · Nature Genetics · doi:10.1038/ng0194-84 · Cited by 844
Research works printed but not linked: 1
- Hudson, T. et al. An STS-based map of the human genome. Science 270, 1945–1954, with supplementary data from the Whitehead Institute/MIT Center for Genome Research, human genetic mapping project, data release 10(May 1996) (1995). · DOI · Paper page
Cited by
Items 701–800 of 1,020
Ethnic Differences in Iron Status
Kang, W., Barad, A., Clark, A. G., Wang, Y., Xu, L., Gu, Z., & O'Brien, K. O. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab035 · Cited by 79
Richardson, D. R., & Lok, H. C. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.009 · Cited by 83
Lipiński, P., Styś, A., & Starzyński, R. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1018-1 · Cited by 85
“The hereditary hemochromatosis protein, HFE, which is responsible for type 1 hemochromatosis, was identified over 15 years ago [98].”
BackgroundA systematic review of the association between fatigue and genetic polymorphisms
Wang, T., Yin, J., Miller, A. H., & Xiao, C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.007 · Cited by 81
“Fernandez-de-las-Penas et al. (2012) examined the influence of COMT Val158Met genotypes on cancer-related fatigue in breast cancer survivors; their results suggested that breast cancer survivors carrying the Met/Met genotype reported higher levels of fatigue.”
BackgroundInfluentialMurphy, S., Curran, M. D., McDougall, N., Callender, M. E., O'Brien, C. J., & Middleton, D. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03076.x · Cited by 76
Correlation Between Genotype and Phenotype in Hereditary Hemochromatosis: Analysis of 61 Cases
Sham, R. L., Ou, C., Cappuccio, J. D., Braggins, C., Dunnigan, K. J., & Phatak, P. D. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0148 · Cited by 76
“account for 80-90% of hereditary hemochroma- Fifty-one of the 61 patients have undergone tosis cases ( 15 ,16,17).”
BackgroundMolecular Genetics of Neurodegenerative Dementias
Hinz, F. I., & Geschwind, D. H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023705 · Cited by 73
“Linkage analysis led to the rapid identification of a number of highly penetrant disease-causing mutations (Kerem et al. 1989; MacDonald et al. 1993; Hästbacka et al. 1994; Feder et al. 1996; Poorkaj et al. 1998; Amir et al. 1999).”
BackgroundInhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics
Huang, J., Zhang, J., Ma, J., Ma, J., Liu, J., Wang, F., & Tang, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9678625 · Cited by 80
“Recessive mutations in the hemochromatosis gene (Hfe) are strongly associated with iron overload [55].”
Pichler, I., Minelli, C., Sanna, S., Tanaka, T., Schwienbacher, C., Naitza, S., Porcu, E., Pattaro, C., Busonero, F., Zanon, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq552 · Cited by 76
“Indeed, common variants in the transferrin (TF) gene have been confirmed to regulate serum transferrin levels, and the C282Y mutation in the HFE gene, found in patients with hereditary hemochromatosis (14), has been associated with iron, transferrin and transferrin saturation (15,16).”
BackgroundA Drosophila model for toxicogenomics: Genetic variation in susceptibility to heavy metal exposure
Zhou, S., Luoma, S. E., Armour, G. S., Thakkar, E., Mackay, T. F. C., & Anholt, R. R. H. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006907 · Cited by 78
Siah, C. W., Trinder, D., & Olynyk, J. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.022 · Cited by 96
Real-Time Detection of Nucleic Acid Interactions by Total Internal Reflection Fluorescence
Lehr, H.-P., Reimann, M., Brandenburg, A., Sulz, G., & Klapproth, H. (2003) · Analytical Chemistry · doi:10.1021/ac0206519 · Cited by 75
Brady, J. J., Roberts, A., Morgan, R. R., Whatley, S. D., Rowlands, G. L., Watson, R., Elder, G. H., Jackson, H. A., Worwood, M., Darby, C., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00148.x · Cited by 78
Aguilar‐Martinez, P., Bismuth, M., Picot, M., Thelcide, C., Pageaux, G.-P., Blanc, F., Blanc, P., Schved, J., & Larrey, D. G. (2001) · Gut · doi:10.1136/gut.48.6.836 · Cited by 82
Celtic Origin of the C282Y Mutation of Hemochromatosis
Lucotte, G. (1998) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1998.0212 · Cited by 82
Suzuki, Y., Saito, H., Suzuki, M., Hosoki, Y., Sakurai, S., Fujimoto, Y., & Kohgo, Y. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200208001-00007 · Cited by 75
McCune, A., Al-Jader, L. N., May, A. M., Hayes, S. L., Jackson, H. A., & Worwood, M. (2002) · Human Genetics · doi:10.1007/s00439-002-0824-1 · Cited by 80
Iron overload in the liver diagnostic and quantification
Alústiza, J. M., Castiella, A., de Juan, M. D., Emparanza, J. I., Artetxe, J., & Uranga, M. U. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.11.012 · Cited by 74
Lambrecht, R. W., Sterling, R. K., Naishadham, D., Stoddard, A. M., Rogers, T. E., Morishima, C., Morgan, T. R. M., & Bonkovsky, H. L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.053 · Cited by 81
Behavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors
Mast, A. E., Foster, T. M., Pinder, H. L., Beczkiewicz, C. A., Bellissimo, D. B., Murphy, A. T., Kovacevic, S., Wroblewski, V. J., & Witcher, D. R. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01823.x · Cited by 75
Genome-wide association studies and genetic risk assessment of liver diseases
Krawczyk, M. J., Müllenbach, R., Weber, S. N., Zimmer, V., & Lammert, F. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.170 · Cited by 77
“In patients who are homozygous for a mutation in the hemochromatosis gene HFE resulting in Cys282Tyr (identified in 1996)”
BackgroundEstimating the Efficacy and Efficiency of Cascade Genetic Screening
Krawczak, M., Cooper, D. N., & Schmidtke, J. (2001) · The American Journal of Human Genetics · doi:10.1086/321973 · Cited by 74
“Feder et al. (1996) identified a genetic change in the HFE gene on chromosome 6 which appears to underlie most cases of HH, and a genetic test for HFE mutations identifies 190% of atrisk individuals in the United Kingdom (The U.K. Haemochromatosis Consortium 1997).”
BackgroundSutton, A., Nahon, P., Pessayre, D., Rufat, P., Poiré, A., Ziol, M., Vidaud, D., Barget, N., Ganne-Carrié, N., Charnaux, N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2566 · Cited by 75
“About 80% of hereditary hemochromatosis patients are homozygous for the Cys282Tyr HFE mutation ( 32 , 33).”
BackgroundGenetic Disorders Affecting Proteins of Iron Metabolism: Clinical Implications
Sheth, S., & Brittenham, G. M. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.443 · Cited by 75
Discrepancies between genotype and phenotype in hematology: an important frontier
Beutler, E. (2001) · Blood · doi:10.1182/blood.v98.9.2597 · Cited by 78
Aguilar‐Martinez, P., Schved, J., & Brissot, P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40998.x · Cited by 76
“The HFE gene codes for a 343 amino acids protein that has a MHC class I-like structure (1).”
BackgroundInfluentialCD8+CD28– T cells: Certainties and uncertainties of a prevalent human T‐cell subset
Arosa, F. A. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01057.x · Cited by 73
Testing Departure from Hardy–Weinberg Proportions
Wang, J., & Shete, S. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-555-8_6 · Cited by 73
Pincus, M. R., Tierno, P. M., Fenelus, M., Bowne, W. B., & Bluth, M. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00021-x · Cited by 75
AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis
Hattori, A., Wakusawa, S., Hayashi, H., Harashima, A., Sanae, F., Kawanaka, M., YAMADA, G., Yano, M., & Yoshioka, K. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00086-x · Cited by 76
Martinelli, A. L. C., Franco, R. F., Villanova, M. G., Figueiredo, J. F. C., Secaf, M., Tavella, M. H., Ramalho, L. N. Z., Zucoloto, S., & Zago, M. A. (1999) · Acta Haematologica · doi:10.1159/000040991 · Cited by 74
“Recently, 2 mutations in the HFE gene on chromosome 6 were discovered to be associated with HH, which is arguably the most common genetic disease affecting white Europeans (estimated disease prevalence of 1/300 in Northern European populations) [ ,”
BackgroundBeyond the Signal Sequence: Protein Routing in Health and Disease
Castro-Fernández, C., Maya‐Núñez, G., & Conn, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0010 · Cited by 76
“The majority of North American patients with HC have a mutation in cysteine 282 (to tyrosine) in a major histocompatibility complex (MHC) class I-like gene, called hemochromatosis gene (HFE) (127, 128).”
BackgroundInfluentialLimdi, J. K., & Crampton, J. R. (2004) · QJM · doi:10.1093/qjmed/hch065 · Cited by 70
Mullighan, C. G., Marshall, S. E., Bunce, M., & Welsh, K. (1999) · Genes and Immunity · doi:10.1038/sj.gene.6363653 · Cited by 73
Wessling-Resnick, M. (1999) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239991209318 · Cited by 72
Tamiya, G., Ôta, M., Katsuyama, Y., Shlina, I., Oka, A., Makino, S., Kimura, M., & Inoko, H. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb02972.x · Cited by 73
Corsi, B., Levi, S., Cozzi, A., Corti, A., Altimare, D., Albertini, A., & Arosio, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01330-7 · Cited by 73
Theurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., & Weiss, G. (2005) · BioMetals · doi:10.1007/s10534-005-3710-1 · Cited by 72
A Highly Conserved Major Histocompatibility Complex Class I-Related Gene in Mammals
Yamaguchi, H., Hirai, M., Kurosawa, Y., & Hashimoto, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7379 · Cited by 72
Schatzkin, A., Abnet, C. C., Cross, A. J., Gunter, M., Pfeiffer, R., Gail, M., Lim, U., & Davey-Smith, G. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0070 · Cited by 59
“HFE is a gene involved in iron absorption; it is associated with the iron overload condition of hereditary hemochromatosis (52).”
BackgroundIron as a comorbid factor in chronic viral hepatitis
Bonkovsky, H. L. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05390.x · Cited by 77
“Most causes of hereditary hemochromatosis are due to a single homozygous mutation (nt: g845a) of the HFE gene, which produces the now familiar substitution of tyrosine for cysteine at amino acid 282 of the HFE protein [the C282Y mutation”
BackgroundHFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma
Lauret, E. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04115-6 · Cited by 72
“In 1996 the gene currently called HFE was described”
BackgroundBonkovsky, H. L., & Lambrecht, R. W. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70116-1 · Cited by 79
Kotze, M. J., de Villiers, J. N. P., Rooney, R. N., Grobbelaar, J. J., Mansvelt, E. P. G., Bouwens, C. S. H., Carr, J. A., Stander, I. A., & du Plessis, L. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0349 · Cited by 78
Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening
McLaren, G. D., McLaren, C. E., Adams, P. C., Barton, J. C., Reboussin, D. M., Gordeuk, V. R., Acton, R. T., Harris, E. L., Speechley, M. R., Sholinsky, P. D., et al. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/907356 · Cited by 78
Fine Localization of a Major Disease-Susceptibility Locus for Diffuse Panbronchiolitis
Keicho, N., Ohashi, J., Tamiya, G., Nakata, K., Taguchi, Y., Azuma, A., Ohishi, N., Emi, M., Park, M. H., Inoko, H., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302786 · Cited by 72
“matosis in whites, linkage-disequilibrium mapping and haplotype analysis subsequent to conventional linkage analysis often have been used successfully for high-resolution mapping and cloning of the disease genes (Kerem et al. 1989; Feder et al. 1996).”
BackgroundMethodEl‐Serag, H. B., Inadomi, J. M., & Kowdley, K. V. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00003 · Cited by 75
Gene Mapping in Isolated Populations: New Roles for Old Friends?
Jorde, L. B., Watkins, W. S., Kere, J., Nyman, D., & Eriksson, A. W. (1999) · Human Heredity · doi:10.1159/000022891 · Cited by 78
Blanc, J., de Lédinghen, V., Bernard, P., de Verneuil, H., Winnock, M., Bail, B. L., Carles, J., Saric, J., Balabaud, C. P., & Bioulac‐Sage, P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80250-0 · Cited by 77
Ionizing radiation and genetic risks
Sankaranarayanan, K., & Chakraborty, R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00106-8 · Cited by 74
Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene
Waalen, J., Felitti, V., Gelbart, T., Ho, N. J., & Beutler, E. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.6.522 · Cited by 71
HLA and disease: guilt by association
Howell, W. M. (2013) · International Journal of Immunogenetics · doi:10.1111/iji.12088 · Cited by 75
“, 1975), prior to discovery of the HFE gene (Feder et al., 1996).”
BackgroundLubitz, S. A., Goldbarg, S. H., & Mehta, D. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.10.003 · Cited by 78
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
de Souza, R. P., Romano‐Silva, M. A., Lieberman, J. A., Meltzer, H. Y., Wong, A. H. C., & Kennedy, J. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1193-9 · Cited by 75
Camaschella, C., Roetto, A., & Gobbi, M. D. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.35635 · Cited by 82
London, W. T., & McGlynn, K. A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0039 · Cited by 95
Iron homeostasis: new players, newer insights
Edison, E. S., Bajel, A. R., & Chandy, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01143.x · Cited by 89
“The C282Y mutation replaces a cysteine, required for a disulfide bridge, which is necessary for the binding of HFE to b2-microglobulin (99).”
BackgroundHolmström, P., Marmur, J., Eggertsen, G., Gåfvels, M., & Stål, P. (2002) · Gut · doi:10.1136/gut.51.5.723 · Cited by 77
Mutations of the Hereditary Hemochromatosis Candidate GeneHLA-Hin Porphyria Cutanea Tarda
Santos, M. M., Clevers, H. C., & Marx, J. J. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361817 · Cited by 71
Genetic Epidemiology and the Future of Disease Prevention and Public Health
Khoury, M. J. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017940 · Cited by 71
“Recent examples of gene discoveries in diseases of significant public health impact include the gene for hereditary hemochromatosis, the most common autosomal recessive disorder (affecting 3 to 8 per 1,000 persons), which leads to significant morbidity and mortality from iron overload (7); the breast cancer genes BRCA…”
BackgroundHealthy human aging: intrinsic and environmental factors
Sgarbieri, V. C., & Pacheco, M. T. B. (2017) · Brazilian journal of food technology/Brazilian Journal of Food Technology · doi:10.1590/1981-6723.00717 · Cited by 84
The transition from genomics to phenomics in personalized population health
Yurkovich, J. T., Evans, S. J., Rappaport, N., Boore, J. L., Lovejoy, J. C., Price, N. D., & Hood, L. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00674-x · Cited by 81
Pankow, J. S., Boerwinkle, E., Adams, P. C., Güallar, E., Leiendecker‐Foster, C., Rogowski, J., & Eckfeldt, J. H. (2008) · Translational research · doi:10.1016/j.trsl.2008.05.005 · Cited by 71
“All C282Y homozgyotes C282Y/C282Y) were verified at CLIA-certified Clinical aboratories of the University of Minnesota Medical Center, airview, using a restriction endonuclease method.(1)”
MethodDistante, S., Bjøro, K., Hellum, K. B., Myrvang, B., Berg, J. P., Skaug, K., Raknerud, N., & Bell, H. (2002) · Liver International · doi:10.1046/j.0106-9543.2002.01672.x · Cited by 70
Barton, J. C., & Acton, R. T. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9826930 · Cited by 83
“Abbreviations BMI: Body mass index CRP: C-reactive protein DMT1: Divalent metal transporter 1 HLA: Human leukocyte antigen HEIRS Study: Hemochromatosis and Iron Overload Screening Study HOMA: Homeostasis model assessment IL-6: Interleukin-6 IR: Insulin resistance MetS: Metabolic syndrome MHC: Major histocompatibility…”
InfluentialEvidence for HLA-related susceptibility for stroke in children with sickle cell disease
Styles, L. A., Hoppe, C. C., Klitz, W., Vichinsky, E. P., Lubin, B. H., & Trachtenberg, E. (2000) · Blood · doi:10.1182/blood.v95.11.3562 · Cited by 70
Iron transport across cell membranes: molecular understanding of duodenal and placental iron uptake
Srai, S. K., Bomford, A. B., & McArdle, H. J. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0003 · Cited by 101
Iron transport: emerging roles in health and disease
Goswami, T., Rolfs, A., & Hediger, M. A. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-159 · Cited by 71
Kartikasari, A. E. R., Georgiou, N., Visseren, F. L. J., Kats-Renaud, H. J. V., van Asbeck, B. S., & Marx, J. J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4700fje · Cited by 77
“The autosomal recessive mutation of the HFE gene is common among the Caucasian population with prevalence of 10% and is responsible for 80–90% of hemochromatosis cases (3).”
BackgroundThe Quality of Media Reports on Discoveries Related to Human Genetic Diseases
Holtzman, N. A., Bernhardt, B. A., Mountcastle-Shah, E., Rodgers, J. E., Tambor, E. S., & Geller, G. (2005) · Public Health Genomics · doi:10.1159/000086756 · Cited by 84
Payne, A. M., Morris, A. G., Downes, S. M., Johnson, S., Bird, A. C., Moore, A. T., Bhattacharya, S. S., & Hunt, D. M. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.611 · Cited by 74
Rossi, E., Olynyk, J. K., Cullen, D. J., Papadopoulos, G. A., Bulsara, M. K., Summerville, L., & Powell, L. W. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.162 · Cited by 72
“Recently, a novel MHC class 1-like candidate gene, termed HFE, for hereditary hemochromatosis containing two missense mutations was identified ( 1 ). Homozygosity for the C282Y mutation has been observed in 85‐90% of patients of Northern European origin with typical hereditary hemochromatosis (2‐ 4) . The H63D mutatio…”
BackgroundMethodHerrmann, T., Muckenthaler, M., van der Hoeven, F., Brennan, K., Gehrke, S. G., Hubert, N., Sergi, C., Gröne, H.-J., Kaiser, I., Gosch, I., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0508-x · Cited by 69
Golfeyz, S., Lewis, S. C., & Weisberg, I. S. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1496016 · Cited by 69
“A guanine to adenine (G to A) missense mutation at nucleotide position 845 in the gene sequence causes substitution of tyrosine (Y) for cysteine (C) at the 282 position in the amino acid (AA) sequence [6,7].”
BackgroundMakui, H., Soares, R. J., Jiang, W., Constante, M., & Santos, M. M. (2005) · Blood · doi:10.1182/blood-2005-02-0629 · Cited by 69
“complex class I (MHC-I)-like protein that requires β2-microglobulin (β2m) for cell surface expression.(2) A link between HFE and cellular iron metabolism is suggested by the”
BackgroundCompound overload of copper and iron in patients with Wilson's disease
Hayashi, H., Yano, M., Fujita, Y., & Wakusawa, S. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0326-7 · Cited by 70
“In 1996, 3 years after the cloning of the ATP7B gene in WD, a missense mutation, C282Y, of the HH gene (HFE) was identified in the majority of Caucasian patients with HH.12 Consequent studies on iron overload in WD indicate that a few exceptional cases are complicated with C282Y,13,14 but most patients are free from H…”
BackgroundPietrangelo, A., & Trautwein, C. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0019 · Cited by 79
“The most common form of hemochromatosis affects individuals of northern European descent and is due to a single-base transition that causes the substitution of tyrosine for cysteine at position 282 (C282Y) of the HFE protein”
BackgroundConservation and diversification of MHC class I and its related molecules in vertebrates
Hashimoto, K., Okamura, K., Yamaguchi, H., Ototake, M., Nakanishi, T., & Kurosaiva, Y. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01384.x · Cited by 73
Brittenham, G. M., Sheth, S., Allen, C. J., & Farrell, D. E. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90059-9 · Cited by 77
Genetic Hemochromatosis, a Celtic Disease: Is It Now Time for Population Screening?
Byrnes, V., Ryan, E. M., Barrett, S., Kenny, P., Mayne, P., & Crowe, S. F. (2001) · Genetic Testing · doi:10.1089/109065701753145583 · Cited by 75
Haemochromatosis gene C282Y homozygotes in an elderly male population
Willis, G. A., Wimperis, J. Z., Smith, K., Fellows, I., & Jennings, B. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02195-9 · Cited by 69
Vanclooster, A., van Deursen, C., Jaspers, R., Cassiman, D., & Koek, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.006 · Cited by 68
Revisiting hemochromatosis: genetic vs. phenotypic manifestations
Anderson, G. J., & Bardou‐Jacquet, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5512 · Cited by 71
“Interest in this area was piqued soon after the cloning of the HFE gene with the recognition that HFE was a non-classical major histocompatibility complex (MHC) class I-like protein (5), and is consistent with the earlier association of HH with the HLA system (49).”
BackgroundResultIron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 76
Gallego, C. J., Burt, A., Sundaresan, A. S., Ye, Z., Shaw, C., Crosslin, D. R., Crane, P. K., Fullerton, S. M., Hansen, K., Carrell, D., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.08.008 · Cited by 77
“Future studies will be needed to address the question of clinical penetrance of HH in non-Europeans, who have a considerably lower frequency of HH-causing HFE variants.8 In summary, we evaluated the diagnostic rate and estimated the penetrance of iron overload and associated organ damage for the two most common HH gen…”
BackgroundMethodInfluentialRyan, J. D., Ryan, E., Fabre, A., Lawless, M. W., & Crowe, J. (2010) · Hepatology · doi:10.1002/hep.23814 · Cited by 66
“Although it is a disease of variable penetrance and considerable heterogeneity, the vast majority of patients with HH are homozygous for the C282Y mutation.(3,4) The mutant C282Y HFE protein is unable to bind beta-2-microglobulin and fails to reach the cell membrane, resulting in a misfolded, nonfunctional protein.”
BackgroundPretorius, E., Bester, J., Vermeulen, N., Lipiński, B., Gericke, G. S., & Kell, D. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085271 · Cited by 72
“The relevant ( HFE ) gene discovery was only reported in 1996 [23].”
BackgroundLatour, C., Besson‐Fournier, C., Meynard, D., Silvestri, L., Gourbeyre, O., Aguilar‐Martinez, P., Schmidt, P. J., Fleming, M. D., Roth, M., & Coppin, H. (2016) · Hepatology · doi:10.1002/hep.28254 · Cited by 67
Pathophysiology of Hereditary Hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923313 · Cited by 65
“It was clear from the primary structure of the HFE protein that it was unlikely to have metal transporter characteristics.(2) HFE, like other MHC class I molecules, is physically associated with b2-microglobulin (b2M).”
BackgroundSelf-citationDistante, S., Berg, J. P., & Lande, K. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750026290 · Cited by 75
Hemochromatosis and Vibrio vulnificus Wound Infections
Barton, J. C., & Acton, R. T. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31819069c1 · Cited by 67
“3.(1) HFE C282Y originated in Europe and was spread by population movements, possibly including Viking migrations.”
BackgroundInfluentialRamsay, A. J., Quesada, V., Sanchez, M., Garabaya, C., Sardà, M. P., Baiget, M., Remacha, A., Velasco, G., & López-Otín, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp315 · Cited by 64
Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network
Chen, Z., Tang, H., Qayyum, R., Schick, U. M., Nalls, M. A., Handsaker, R. E., Li, J., Lu, Y., Yanek, L. R., Keating, B. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt087 · Cited by 84
“Two known HFE mutations C282Y (rs1800562) and H63D (rs1799945) cause hereditary hemochromatosis, an autosomal recessive iron storage disorder (13).”
BackgroundThe Hemochromatosis 845 G→A and 187 C→G Mutations: Prevalence in Non-Caucasian Populations
Cullen, L. M., Gao, X., Easteal, S., & Jazwinska, E. C. (1998) · The American Journal of Human Genetics · doi:10.1086/301878 · Cited by 72
“Some 80%–100% of hemochromatosis patients are homozygous for 845 GrA (Beutler et al. 1996; Callandro et al. 1996; Feder et al. 1996; Jazwinska et al. 1996; Jouanolle et al. 1996), providing strong evidence that 845 GrA in HFE is the primary causative mutation in hemochromatosis.”
BackgroundMethodInfluentialIncreased Prevalence of theHFE C282YHemochromatosis Allele in Women with Breast Cancer
Kallianpur, A. R., Hall, L. D., Yadav, M., Christman, B. W., Dittus, R. S., Haines, J. L., Parl, F. F., & Summar, M. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0188 · Cited by 74
Malfroy, L., Roth, M., Carrington, M. N., Borot, N., Volz, A., Ziegler, A., & Coppin, H. (1997) · Genomics · doi:10.1006/geno.1997.4800 · Cited by 72
Kyger, E. M., Krevolin, M. D., & Powell, M. J. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2687 · Cited by 72
Smith, B. N., Kantrowitz, W., Grace, N. D., Greenberg, M. S., Patton, T. J., Ookubo, R., Sorger, K., Semeraro, J. G., Doyle, J. R., Cooper, A. G., et al. (1997) · Hepatology · doi:10.1002/hep.510250622 · Cited by 69
Review article Microsatellites in the HLA region: an overview
Foissac, A., Crouau‐Roy, B., Fauré, S., Thomsen, M., & Cambon‐Thomsen, A. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02740.x · Cited by 67
Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival
Moalem, S., Weinberg, E. D., & Percy, M. E. (2004) · BioMetals · doi:10.1023/b:biom.0000018375.20026.b3 · Cited by 66
“Two mutations (C282Y and H63D) in a ‘non-classical’ HLA class-I gene named HFE have been found to be associated with hereditary hemochromatosis (Feder et al. 1996).”
Metadata
- Authors
- Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prass, C. E., Quintana, L., Starnes, S. M., Schatzman, R. C., Brunke, K. J., Drayna, D. T., Risch, N. J., Bacon, B. R., & Wolff, R. K.
- Affiliations
- Stanford Medicine (US)
- Saint Louis University (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1996-08
- Volume
- 13
- Issue
- 4
- Pages
- 399-408
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2002605005
- Cited by
- 3,664
- References
- 78
- Citations by year
- 2026: 27 · 2025: 27 · 2024: 38 · 2023: 47 · 2022: 51 · 2021: 47 · 2020: 67 · 2019: 50 · 2018: 58 · 2017: 92 · 2016: 87 · 2015: 80 · 2014: 74 · 2013: 94 · 2012: 96
- FWCI
- 124.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HLA-H, HLA-F, missense mutations, iron metabolism, iron accumulation, linkage disequilibrium, haplotype analysis, homozygosity, gene inactivation
- MeSH terms
- Hemochromatosis Protein, Alleles, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 6, Cloning, Molecular, Cysteine, Biological Evolution, Genes, MHC Class I, Genetic Markers, Haplotypes, Hemochromatosis, HLA Antigens, Humans, Major Histocompatibility Complex, Membrane Proteins, Molecular Sequence Data, RNA, Messenger, Histocompatibility Antigens Class I, Linkage Disequilibrium, Gene Expression, Sequence Alignment, Sequence Homology, Amino Acid, DNA Primers, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.